Teddy European Network of Excellence for Paediatric Research was funded in 2005 with the aim to favor the integration of the paediatric pharmacological research activities and contribute to the promotion of safe and efficacious medicines for children.

TEDDY is a Network of Excellence (NoE), strongly proactive in the promotion and implementation of adequate health policies and a social awareness on the importance of the paediatric medicines across Europe.

Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from more than 20 countries aimed at facilitating the performance of good quality paediatric studies and research.

TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.

Moreover, TEDDY is member of Enpr-EMA Coordinating Group.

Latest News

2005, 2020

International Clinical Trials Day is held on 20 May each year since 2005 to commemorate the day that James Lind began his famous trial for the scurvy. The objective is to make this

1205, 2020

DH-BIO Statement on human rights considerations relevant to the COVID-19 pandemic

The Committee on Bioethics (DH-BIO) - Council of Europe released “DH-BIO Statement on human rights considerations relevant to the COVID-19 pandemic”, recalling the fundamental principles, based on the respect for human dignity and